These look potentially interesting for pulsed or lower level dosing (?)
Types of IL-17 Inhibitors
IL-17 inhibitors are a type of drug called “injectables” that are self-administered by subcutaneous injection applied with a needle under the skin. All three IL-17 inhibitors follow a similar dosing schedule of once a week during the first month, followed by once-monthly dosing for maintenance after the first five weeks.11
Cosentyx (Secukinumab), Taltz (Ixekizumab), and Siliq (Brodalumab) are similar types of drugs, but they each have slightly different dosing. Be sure to ask your pharmacist or a healthcare provider about the specific dosing schedule for the type of IL-17 inhibitor you’re prescribed.
These IL-17 Inhibitors Are FDA Approved
Three IL-17 inhibitors—Cosentyx (secukinumab), Taltz (ixekizumab), and Siliq (brodalumab)—are FDA-approved for the treatment of plaque psoriasis and psoriatic arthritis.
Numerous studies have established that IL-17 inhibitors are generally well-tolerated, safe, and provide significant benefits for people with psoriasis, psoriatic arthritis, and ankylosing spondylitis.13
However, these biologic medications are not without risks. Most notably, IL-17 inhibitors are immunosuppressants. They tone down the immune system, which increases the risk of serious infections. Immunosuppressive therapies also weaken the immune system’s ability to detect and destroy cancer cells or fight the infections that cause cancer
More information on these drugs:
Prices, at least for secukinumab, in India, seem to be commonly in the $50 to $150 range (per 150ml) … 82 rupees to the US$. But it does seem to have refrigeration requirements, which makes it difficult to ship from India to other parts of the world (not sure if this applies to the powder and the liquid formula, or just the liquid formula - do your research if buying).
